US Broker Ratings

The Ensign Group, Inc. (ENSG): Investor Outlook and 12% Upside Potential

Investors have their eyes on The Ensign Group, Inc. (NASDAQ: ENSG), with its impressive market presence in the healthcare sector and a remarkable potential upside of 12.01%. Standing strong with..

Genmab A/S (GMAB) Stock Analysis: Exploring a Promising 22% Upside Potential

In the ever-evolving landscape of biotechnology, Genmab A/S (NASDAQ: GMAB) stands as a significant player, particularly in the sector of antibody-based cancer treatments. With a market capitalization of $18.76 billion,..

Alcon Inc. (ALC) Investor Outlook: Exploring a Promising 24% Upside Potential

Alcon Inc. (NYSE: ALC), a Swiss-based leader in the healthcare sector, particularly in medical instruments and supplies, stands as a beacon of innovation in the eye care industry. With a..

ICON plc (ICLR) Stock Analysis: Exploring a 25.30% Potential Upside in the Healthcare Sector

As investors navigate the ever-evolving landscape of the healthcare sector, ICON plc (NASDAQ: ICLR) emerges as a notable player with a compelling investment thesis. Headquartered in Dublin, Ireland, ICON plc..

Universal Health Services, Inc. (UHS) Stock Analysis: Navigating the Healthcare Titan’s Growth Potential and Strategic Position

Universal Health Services, Inc. (NYSE: UHS) stands as a formidable player in the healthcare sector, with a robust market capitalization of $14.76 billion. Headquartered in King of Prussia, Pennsylvania, UHS..

Waystar Holding Corp. (WAY) Stock Analysis: Analyzing a Promising 37.54% Upside in the Healthcare Information Sector

Waystar Holding Corp. (WAY), a burgeoning force in the health information services industry, has captured investor attention with its potential upside of 37.54%, according to consensus analyst ratings. With its..

DaVita Inc. (DVA) Stock Analysis: Evaluating the 20% Upside Potential Amidst Healthcare Sector Dynamics

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector, specializes in providing kidney dialysis services across the United States. Operating numerous outpatient dialysis centers, DaVita is pivotal in..

Corcept Therapeutics (CORT) Stock Analysis: Unlocking a 74.99% Potential Upside in the Biotech Sector

Corcept Therapeutics Incorporated (NASDAQ: CORT) presents an intriguing opportunity for investors looking to capitalize on the dynamic biotechnology sector. With a current market capitalization of $8.14 billion, this Redwood City,..

Masimo Corporation (MASI) Stock Analysis: Exploring a 22.70% Potential Upside in the Healthcare Sector

Masimo Corporation (NASDAQ: MASI), a leader in the healthcare sector specializing in medical devices, presents a compelling opportunity for investors seeking exposure to innovative patient monitoring technologies. With a market..

Revvity, Inc. (RVTY) Stock Analysis: Investor Outlook and Potential 15.67% Upside

Revvity, Inc. (NYSE: RVTY), a key player in the healthcare sector, specifically in the diagnostics and research industry, offers a compelling investment narrative with its diverse product offerings and promising..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Is the Current Price Justified Amidst Robust Revenue Growth?

IDEXX Laboratories, Inc. (NASDAQ: IDXX) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Westbrook, Maine, IDEXX specializes in developing and..

Bristol-Myers Squibb (BMY) Stock Analysis: A 14% Upside Potential Amidst Strong Dividend Yield

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, presents a compelling case for investors seeking stability and growth. With its extensive portfolio of biopharmaceutical products, the company..

Natera, Inc. (NTRA) Stock Analysis: A Healthcare Pioneer with Strong Buy Ratings and Growth Potential

Natera, Inc. (NASDAQ: NTRA) is a formidable player in the diagnostics and research sector, garnering significant attention from investors due to its innovative approach and promising growth trajectory. Headquartered in..

STERIS plc (STE) Investor Outlook: Navigating Growth Potential with a 6.96% Upside

STERIS plc (NYSE: STE), a prominent player in the healthcare sector, continues to capture the attention of investors with its robust market presence in the medical devices industry. With a..

Incyte Corporation (INCY) Stock Analysis: Unlocking Growth Potential Amidst a Challenging Biotech Landscape

Incyte Corporation (NASDAQ: INCY) stands out in the biotechnology sector, a realm known for its innovation and rapid advances in medical science. With a substantial market capitalization of $20.04 billion,..

ResMed Inc. (RMD) Stock Analysis: Healthcare Giant with a 17% Potential Upside

ResMed Inc. (NYSE: RMD) stands as a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $36.6 billion, the company..

The Cigna Group (CI): Investor Outlook Reveals An 18% Potential Upside Amidst Robust Revenue Growth

The Cigna Group (NYSE: CI), a towering entity in the healthcare plans industry, has recently garnered substantial investor interest, particularly due to its potential upside of 18.07%. Operating in the..

BioNTech SE (BNTX) Investor Outlook: Exploring a 42.51% Potential Upside Amidst Strong Analyst Confidence

BioNTech SE (NASDAQ: BNTX), the German biotechnology company that became synonymous with COVID-19 vaccine development, continues to intrigue investors with its promising pipeline of immunotherapies targeting cancer and infectious diseases...

Labcorp Holdings Inc. (LH) Stock Analysis: Unveiling a 12.82% Potential Upside Amid Strong Buy Ratings

Labcorp Holdings Inc. (NYSE: LH), a pivotal player in the healthcare sector’s Diagnostics & Research industry, is garnering substantial attention from investors, thanks to its promising growth potential and robust..

Moderna, Inc. (MRNA) Stock Analysis: Exploring a 57% Potential Upside Amid Biotech Volatility

Moderna, Inc. (NASDAQ: MRNA) stands at the forefront of the biotechnology sector, known for its groundbreaking work in messenger RNA (mRNA) medicines. Headquartered in Cambridge, Massachusetts, the company has garnered..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds